Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - November 2025

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Building Resilient, Sustainable Pharma Supply Chains

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The collaboration ultimately benefits oncology patients, as life science companies will be able to access their cancer journey data more efficiently.

Ontada Partners With Datavant for Faster Access to RWD

The latest news for pharma industry insiders.

Pharma Pulse 11/15/24: Practical Gains for Pharma AI Use, Small-Molecules Are More Cost Effective & more

Investigators explore this potential association, including how it affects a child’s first two years of life. 

Does Prenatal Exposure to the SARS-CoV-2 Infection Impact Child Neurodevelopment?

The 50,000 square-foot plant is expected to augment the compounding and fulfillment experience for telehealth companies. 

Strive Compounding Pharmacy Eyes Expansion, Purchases St. Louis Facility

Pharma Pulse 11/14/24: Powering Pipelines Forward, Debates Continue About Pharmacists’ Provider Status & more

A cross-sectional study uses epidemiological patterns to investigate these disparities, while also predicting the potential shift of these patterns by 2050.

Global Disparities in Cancer Burden 

The 13,400 square-foot Belgium site will expand the company’s branded standardized bioprocessing, cryopreservation, and distribution solution for the cell therapy market, with a focus on leukapheresis starting materials.

Cryoport Opens New CoE in Europe

Pharma Pulse 11/13/24: Strategies for Bridging the Sponsor-Site Tech Divide, Innovative Approaches to Chronic Disease Management & more

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.

Understanding the FDA's Exemption for DSCSA Compliance

Videos

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jonathan Colehower, managing director, global operations & supply chain practice at UST, explains how the use of blockchain technology will become more prominent moving forward.

Featured Content

Pharmaceutical Commerce - November 2025

Building Resilient, Sustainable Pharma Supply Chains

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead